We chose the circumsporozoite protein (CSP) and the apical membrane antigen-1 (AMA1) as vaccine antigens for clinical testing, as both are present in sporozoites and liver stages [21], [22] and CSP has induced protective responses against pre-erythrocytic stage malaria in humans [19], [23]. Here, DNAJC5 is linked to malaria.